The majority of people with Parkinson's disease incur Freezing of Gait (FoG), which is not addressed adequately by medication. Cueing is a proven strategy to overcome FoG. The Cue2Walk is a device with automated detection of FoG and provision of rhythmic cues. In this study, the (cost-)effectiveness of the Cue2Walk device as compared to usual care is investigated.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Self-reported quality of life
Timeframe: Baseline (week 0), week 8, week 16, Post-intervention (week 24), week 32
General health-related quality of life
Timeframe: Baseline (week 0), week 8, week 16, Post-intervention (week 24), week 32
Time in Freezing of Gait
Timeframe: Continuously from baseline (week 0) up to week 32